CMLHope.Com
A Worldwide Support Network For Chronic Myelogenous Leukemia
Posted by rob on September 9, 2007 under Uncategorized | Be the First to Comment
AKT/NF-kappaB inhibitor xanthohumol targets cell growth and angiogenesis in hematologic malignancies.
An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells.